Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
705260-08-8
Purity
95%
Vorapaxar inhibits platelet aggregation through the reversible antagonism of protease-activated receptor 1. It is used to reduce thrombotic cardiovascular events in patients with a history of myocardial infarction or peripheral arterial disease.
Properties
Name
Vorapaxar sulfate
Smiles
CCOC(=O)N[C@@H]1CC[C@H]2[C@H](/C=C/C=3C=CC(=CN3)C=4C=CC=C(F)C4)[C@@H]5[C@@H](C)OC(=O)[C@@H]5C[C@@H]2C1.OS(=O)(=O)O
Targets
Please log in to see this information
SDS
Sch 530348 | vorapaxar
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$90
2 mg
$130
5 mg
$240
10 mg
$416
15 mg
$POA
20 mg
$544
25 mg
$672
30 mg
$800
35 mg
$928
40 mg
$1056
45 mg
$1184
50 mg
$1312
75 mg
$2160
100 mg
$POA
Quantity
1
Total amount
$ 240
Sch 530348 | vorapaxar
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
CAS:618385-01-6
0